Table of Contents
ISRN Immunology
Volume 2011, Article ID 194314, 6 pages
Research Article

Umbilical Serum sHLA-G Levels in Preeclamptic Pregnancies with and without Intrauterine Fetal Growth Restriction: A Comparison with Normotensive Pregnancies with Isolated IUGR and Healthy Controls

1Department of Obstetrics and Perinatology, Medical University of Lublin, Jaczewskiego 8 Street, 20-950 Lublin, Poland
2Department of Gastroenterology, Medical University of Lublin, Jaczewskiego 8 Street, 20-950 Lublin, Poland

Received 28 May 2011; Accepted 20 July 2011

Academic Editor: I. Athanassakis

Copyright © 2011 Marzena Laskowska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The aim of this study was the analysis of the umbilical cord serum sHLA-G levels in pregnancies complicated by severe preeclampsia and/or IUGR. Patients and Methods. The study was carried out on 12 preeclamptic patients with appropriate-for-gestational-age weight infants, 14 pregnant patients with severe preeclampsia complicated by IUGR, 7 normotensive patients with isolated IUGR, and 22 healthy controls with uncomplicated pregnancies. Results. Our study revealed higher umbilical serum levels of sHLA-G in preeclamptic pregnancies complicated by IUGR and decreased in the preeclamptic women with the normal fetal growth. The pregnant normotensive patients with isolated IUGR revealed the same levels of sHLA-G as observed in healthy pregnant controls. Conclusions. Lower levels of sHLA-G observed in preeclamptic pregnancies without IUGR may lead to excessive maternal immune reaction against the fetus. Higher levels of sHLA-G in preeclamptic pregnancies with IUGR may reflect the excessive releasing of this molecule to protect fetus, but it may be insufficient to balance disturbed fetomaternal immune relationship. The lack of association with normotensive pregnancies complicated by isolated IUGR may suggest that a different pathomechanism is involved in the impairment of intrauterine fetal growth in both patient groups with pregnancies complicated by isolated IUGR and in the course of preeclampsia.